An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas

NCT01240577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Lymphoma

Interventions

DRUG: IPdR

Sponsor

National Cancer Institute (NCI)